Laddar...
Effectiveness of omalizumab in a patient with a life-threatening episode of bronchospasm and larynx angioedema after exposure to house dust
Omalizumab is a monoclonal antibody against IgE, nowadays approved for the treatment of persistent severe (EU) or moderate-to severe (USA) IgE-mediated asthma but there is also some evidence (case reports and four published clinical trials) on the effectiveness of this medication in urticaria and an...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Termedia Publishing House
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3952055/ https://ncbi.nlm.nih.gov/pubmed/24683397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pdia.2014.40659 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|